Last reviewed · How we verify
NCT04653220
Metabolic Response Evaluation of Low-sugar Snack Bars
NA trial testing Control 1 in Pre Diabetes in 48 participants. Completed in 26 May 2023.
26 May 2023
Quick facts
| Lead sponsor | Singapore Institute of Food and Biotechnology Innovation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | other |
| Enrollment | 48 |
| Start date | 13 November 2019 |
| Primary completion | 26 May 2023 |
| Estimated completion | 26 May 2023 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Control 1 — full drug profile →
- Control 2
- Standard Crokao
- Low sugar variant 1
- Low sugar variant 2
- Low sugar variant 3
- Low sugar variant 4
- Low sugar variant 5
Conditions studied
- Pre Diabetes — all drugs for Pre Diabetes →
- Diabetes — all drugs for Diabetes →
- Obesity — all drugs for Obesity →
Sponsor
Singapore Institute of Food and Biotechnology Innovation
Who can join
Adults 21 to 65, male only, with Pre Diabetes or Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the post-prandial metabolic response and biomarker response, following the consumption of newly developed low glycaemic index (GI) snack bars. The snack bars are formulated with different combinations and ratios of ingredients and food structures. The low sugar products maintaining glucose homeostasis and preventing metabolic problems may have commercial potential as a novel functional ingredient in a variety of fields, including nutrition, medicine, and agriculture.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04653220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Control 1
Trials testing the same drug.
- NCT06942026 — Effects of Chlorhexidine Gluconate, Ozonated Water and Hypochlorous Acid Solutions Used in the Oral Care of Patients Sup · Phase 4 · not yet recruiting
- NCT05823974 — A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults · Phase 1, PHASE2 · completed
Other recruiting trials for Pre Diabetes
Currently open trials in the same condition.
- NCT07252700 — Preventing Diabetes: Impact of an EMR-Based Intervention for Enhanced Pre-Diabetes Management in Primary Care · NA · recruiting
- NCT06986161 — Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals · NA · recruiting
- NCT06426277 — Effectiveness of the Brazilian Diabetes Prevention Program · NA · recruiting
- NCT06387797 — Primary and Secondary Prevention of Type 2 Diabetes Mellitus in Clark County · NA · recruiting
- NCT06555952 — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors · NA · recruiting
Other Singapore Institute of Food and Biotechnology Innovation trials
Trials by the same sponsor.
- NCT07397754 — Sodium-rich COndiments Unifying Health and Taste · NA · recruiting
- NCT06691126 — Pharmacokinetic Study of Terpinolene in Healthy Subjects (PKT Study) · NA · completed
- NCT06421194 — Functional and Nutritional Plant-based Mixed Protein Study (FuN Protein Study) · NA · recruiting
- NCT06119035 — Insulin Modelling Based on Plasma Glucose Measures Via a Minimally-Invasive Glucose Sensor · NA · completed
- NCT06640335 — The Effects of Vegetable Preloading on Postprandial Glycemia, Insulinaemia and Gastric Emptying · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04653220 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Singapore Institute of Food and Biotechnology Innovation
- Last refreshed: 31 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04653220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing